Concepedia

Publication | Closed Access

Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer

187

Citations

39

References

2007

Year

Abstract

These data strongly implied that targeting the KIF4A molecule might hold a promise for the development of anticancer drugs and cancer vaccines as well as a prognostic biomarker in clinic.

References

YearCitations

Page 1